세계의 의료용 영상 시약 시장 보고서(2025년)
Medical Imaging Reagents Global Market Report 2025
상품코드 : 1821686
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의료용 영상 시약 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.9%를 나타내 212억 1,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 맞춤형 의료, 질병의 조기 발견에 대한 주목 증가, 만성 질환의 세계 부담 증가, POC(Point-of-Care) 이미징의 확대, 테라노스틱스의 통합 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향에는 기술의 진보, 만성질환의 유병률 증가, 맞춤형 의료에서의 화상진단, 신흥 시장, 세계적인 확대, 파트너십과 제휴 등이 포함됩니다.

향후 5년간의 성장률 6.9%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 벨기에나 인도에서 조달하는 조영제 및 방사성 의약품의 비용을 밀어올려 영상 진단 비용을 악화시키고 진보된 진단에 대한 환자 접근을 제한함으로써 미국 의료 제산업체에게 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

의료용 영상 시약 시장 성장은 만성 질환의 유병률 증가에 의해 촉진될 것으로 예측됩니다. 만성 질환은 1년 이상 지속되고 지속적인 치료가 필요하며, 정확한 진단과 발견을 위해 의료용 영상 시약을 사용해야 합니다. 주목할 만한 것은 2022년에 미국 암 협회가 보고한, 미국에서의 추정 190만명의 신규 암 환자와 60만 9,360명의 암 관련 사망자였습니다. 또한 IDF Diabetes Atlas Tenth Edition 2021은 2021년에 20세에서 79세까지 5억 3,700만 명이 당뇨병을 앓고 있음을 밝혔으며, 이 수치는 2030년까지 6억 4,300만 명, 2045년까지 7억 8,300만 명으로 증가할 전망입니다. 이 만성 질환의 급증은 의료용 영상 시약 시장 성장의 원동력이 되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Medical imaging reagents are substances utilized by medical practitioners and researchers to enhance the visibility of structures and organs, aiding in the identification, diagnosis, and treatment of diseases. They play a crucial role in visualizing structures or organs, allowing clinicians to improve disease identification and diagnosis.

The main classes of medical imaging reagents include contrast reagents, optical reagents, and nuclear reagents. Contrast agents specifically enhance radiodensity and increase the contrast of structures or fluids in medical imaging by altering the way electromagnetic radiation or ultrasound waves pass through the body. Various technologies involved in these reagents include nanoparticles, fluorescent dyes, radiopharmaceuticals, fluorescent proteins, and quantum dots. These technologies are applied in various imaging modes such as X-ray, CT scan, ultrasound, and MRI scan. Medical imaging reagents find applications in diverse medical conditions, including neurological disorders, cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, nephrological disorders, and others. These reagents are used by various end-users, including biotechnology companies, pharmaceutical companies, and diagnostic labs.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The medical imaging reagents market research report is one of a series of new reports from The Business Research Company that provides medical imaging reagents market statistics, including medical imaging reagents industry global market size, regional shares, competitors with a medical imaging reagents market share, detailed medical imaging reagents market segments, market trends and opportunities, and any further data you may need to thrive in the medical imaging reagents industry. This medical imaging reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical imaging reagents market size has grown strongly in recent years. It will grow from $15.23 billion in 2024 to $16.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing prevalence of diseases, growing aging population, expanding applications, regulatory approvals, strategic collaborations and partnerships.

The medical imaging reagents market size is expected to see strong growth in the next few years. It will grow to $21.21 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine, increasing focus on early disease detection, rising global burden of chronic diseases, expanding point-of-care imaging, integration of theranostics. Major trends in the forecast period include technological advancements, increasing prevalence of chronic diseases, diagnostic imaging in personalized medicine, emerging markets and global expansion, partnerships and collaborations.

The forecast of 6.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. providers by driving up the cost of contrast agents and radiopharmaceuticals sourced from Belgium and India, exacerbating imaging procedure expenses and limiting patient access to advanced diagnostics. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the medical imaging reagents market is anticipated to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting one year or longer and requiring ongoing medical attention, necessitate the use of medical imaging reagents for accurate diagnosis and detection. Notably, in 2022, the American Cancer Society reported an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States. Additionally, the IDF Diabetes Atlas Tenth Edition 2021 revealed that 537 million individuals aged 20 to 79 years had diabetes in 2021, a figure expected to rise to 643 million by 2030 and 783 million by 2045. This surge in chronic diseases is a driving force behind the growth of the medical imaging reagents market.

The medical imaging reagents market is also set to witness growth due to the increasing demand in the pharmaceutical industry. Playing a crucial role in research, drug development, and precision medicine, medical imaging reagents contribute significantly to advancing pharmaceutical endeavors. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported a total pharmaceutical production of $384,200 million (€340,000 million) in Europe in 2022, reflecting a 4.95% increase from the previous year. This heightened demand in pharmaceutical industries is a key factor fueling the growth of the medical imaging reagents market.

A prominent trend in the medical imaging reagents market is the emphasis on product innovations by major companies to maintain their competitive positions. Notably, Aptamer Group plc, a UK-based company, introduced Optimer-Fc in March 2023. Optimer-Fc combines an Optimer binder with an antibody's Fc domain, enabling its use in IHC applications. This innovative reagent facilitates enhanced research, diagnostics, and forensics, offering improved precision and selectivity in detection.

Leading companies in the medical imaging reagents market are concentrating on creating innovative products, such as the cell painting kit, to boost their revenues. This kit features pre-optimized, verified fluorescent probes along with a compatible diluent, designed to streamline the cell painting workflow while ensuring excellent repeatability and validation for use in high-content screening systems. For example, in December 2023, Amazon Web Services (AWS), a US-based company, is revolutionizing drug discovery through high-throughput Cell Painting, an advanced image-based assay for high-content screening. This method enhances the understanding of cellular behaviors and phenotypes. By leveraging AWS's scalable infrastructure, researchers can effectively manage large volumes of cell image data and execute complex image processing tasks. The Cell Painting Batch solution on AWS, utilizing tools like CellProfiler, automates these processes and addresses challenges such as fluctuating workloads, collaboration hurdles, and high computational requirements. This approach accelerates drug discovery while also improving scientific reproducibility and fostering collaboration across laboratories.

In December 2023, Mindray, a multinational medical technology company based in China that specializes in developing and manufacturing medical equipment and accessories, acquired DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition enhances Mindray's global supply chain and broadens its in-vitro diagnostics (IVD) business. DiaSys Diagnostic Systems GmbH, located in Germany, focuses on creating diagnostic system solutions, including automated clinical chemistry analyzers, semi-automated analyzers, and point-of-care instruments.

Major companies operating in the medical imaging reagents market include General Electric Company, Lantheus Holdings Inc., Thermo Fisher Scientific Inc., Bayer AG, Bracco SpA, Siemens AG, PerkinElmer Inc., Cardinal Health Inc., Shimadzu Corporation, Philips Healthcare, SA Laboratoires Andre Guerbet, Canon Medical Systems Corporation, Fujifilm Healthcare, Guerbet Group, Merck KGaA, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Toshiba Corporation, Hologic Inc., Carestream Health Inc., Curium Pharma, Nordion Inc., IBA Molecular, Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications, Jubilant Life Sciences Limited, Mallinckrodt Pharmaceuticals, Nihon Kohden Corporation, Mindray Medical International Limited, Samsung Medison Co. Ltd., Analogic Corporation

North America was the largest region in the medical imaging reagents market in 2024. The regions covered in the medical imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the medical imaging reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical imaging reagents market consists of sales of fluorescent visualizing reagents, supermolecules, and magnetic resonance imaging reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Imaging Reagents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical imaging reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical imaging reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical imaging reagents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Medical Imaging Reagents Market Characteristics

3. Medical Imaging Reagents Market Trends And Strategies

4. Medical Imaging Reagents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medical Imaging Reagents Growth Analysis And Strategic Analysis Framework

6. Medical Imaging Reagents Market Segmentation

7. Medical Imaging Reagents Market Regional And Country Analysis

8. Asia-Pacific Medical Imaging Reagents Market

9. China Medical Imaging Reagents Market

10. India Medical Imaging Reagents Market

11. Japan Medical Imaging Reagents Market

12. Australia Medical Imaging Reagents Market

13. Indonesia Medical Imaging Reagents Market

14. South Korea Medical Imaging Reagents Market

15. Western Europe Medical Imaging Reagents Market

16. UK Medical Imaging Reagents Market

17. Germany Medical Imaging Reagents Market

18. France Medical Imaging Reagents Market

19. Italy Medical Imaging Reagents Market

20. Spain Medical Imaging Reagents Market

21. Eastern Europe Medical Imaging Reagents Market

22. Russia Medical Imaging Reagents Market

23. North America Medical Imaging Reagents Market

24. USA Medical Imaging Reagents Market

25. Canada Medical Imaging Reagents Market

26. South America Medical Imaging Reagents Market

27. Brazil Medical Imaging Reagents Market

28. Middle East Medical Imaging Reagents Market

29. Africa Medical Imaging Reagents Market

30. Medical Imaging Reagents Market Competitive Landscape And Company Profiles

31. Medical Imaging Reagents Market Other Major And Innovative Companies

32. Global Medical Imaging Reagents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Imaging Reagents Market

34. Recent Developments In The Medical Imaging Reagents Market

35. Medical Imaging Reagents Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기